| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
INSERM U341, Service de Diabétologie (V.P., C.R., I.B., G.R.); and INSERM U465, Institut Biomédical des Cordeliers (M.G-M.), Paris, France
Address all correspondence and requests for reprints to: Vincent Poitout, INSERM U341, Service de Diabétologie, Hôtel-Dieu, 1 Place du Parvis Notre Dame, 75004 Paris, France. E-mail: poitout{at}infobiogen.fr
The recently discovered adipose cell-specific hormone called leptin decreases food intake and increases energy expenditure in rodents through a pathway involving hypothalamic leptin receptors, OB-R. In addition, leptin decreases insulin circulating levels independent of the reduction in food intake. Whether or not the hormone has a direct effect on pancreatic ß-cells is not clear, because previous in vitro studies have led to controversial results depending on the animal model used. The present study was designed to investigate the effects of leptin in islets of Langerhans isolated from normal rodents. Three isoforms of the leptin receptor, OB-Ra, b, and f, were detected by RT-PCR analysis of total RNA from rat islets. In static incubations, leptin (10 ng/ml) did not alter basal insulin secretion nor insulin secretion stimulated by glucose alone, potassium chloride, or ketoisocaproic acid. In contrast, insulin secretion stimulated by glucose + 3-isobutyl 1-methylxanthine (IBMX) was inhibited by 34 ± 15% (n = 4, P < 0.05). This was further substantiated in perifusion experiments, in which leptin decreased by 31 ± 3% (n = 5, P < 0.01) glucose + IBMX-stimulated insulin release. Similarly, in mouse islets a significant inhibitory effect of leptin (-31 ± 4%, n = 6, P < 0.05) was observed only on glucose + IBMX-stimulated insulin secretion, with no effect of the hormone on basal nor glucose-stimulated secretion. Finally, leptin was totally inefficient in islets isolated from obese fa/fa rats, which bear a mutation in OB-R. These results suggest that, in normal rodent islets, leptin specifically inhibits IBMX-potentiated glucose-induced insulin secretion, through a direct effect involving at least one of the three isoforms of OB-R expressed in islets.
This article has been cited by other articles:
![]() |
M. H. Vickers, P. D. Gluckman, A. H. Coveny, P. L. Hofman, W. S. Cutfield, A. Gertler, B. H. Breier, and M. Harris The Effect of Neonatal Leptin Treatment on Postnatal Weight Gain in Male Rats Is Dependent on Maternal Nutritional Status during Pregnancy Endocrinology, April 1, 2008; 149(4): 1906 - 1913. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Hagman, M. G. Latour, S. K. Chakrabarti, G. Fontes, J. Amyot, C. Tremblay, M. Semache, J. A. Lausier, V. Roskens, R. G. Mirmira, et al. Cyclical and Alternating Infusions of Glucose and Intralipid in Rats Inhibit Insulin Gene Expression and Pdx-1 Binding in Islets Diabetes, February 1, 2008; 57(2): 424 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Latour, T. Alquier, E. Oseid, C. Tremblay, T. L. Jetton, J. Luo, D. C.-H. Lin, and V. Poitout GPR40 Is Necessary but Not Sufficient for Fatty Acid Stimulation of Insulin Secretion In Vivo Diabetes, April 1, 2007; 56(4): 1087 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jackerott, A. Moldrup, P. Thams, E. D. Galsgaard, J. Knudsen, Y. C. Lee, and J. H. Nielsen STAT5 Activity in Pancreatic {beta}-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes. Diabetes, October 1, 2006; 55(10): 2705 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Vickers, P. D. Gluckman, A. H. Coveny, P. L. Hofman, W. S. Cutfield, A. Gertler, B. H. Breier, and M. Harris Neonatal Leptin Treatment Reverses Developmental Programming Endocrinology, October 1, 2005; 146(10): 4211 - 4216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Seufert Leptin Effects on Pancreatic {beta}-Cell Gene Expression and Function Diabetes, February 1, 2004; 53(90001): S152 - 158. [Abstract] [Full Text] |
||||
![]() |
C. Bjorbaek and B. B. Kahn Leptin Signaling in the Central Nervous System and the Periphery Recent Prog. Horm. Res., January 1, 2004; 59(1): 305 - 331. [Abstract] [Full Text] |
||||
![]() |
D. A. Zieba, M. Amstalden, M. N. Maciel, D. H. Keisler, N. Raver, A. Gertler, and G. L. Williams Divergent Effects of Leptin on Luteinizing Hormone and Insulin Secretion Are Dose Dependent Experimental Biology and Medicine, March 1, 2003; 228(3): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Lee, A. G. Swick, and D. R. Romsos Leptin Constrains Phospholipase C-Protein Kinase C-Induced Insulin Secretion via a Phosphatidylinositol 3-Kinase-Dependent Pathway Experimental Biology and Medicine, February 1, 2003; 228(2): 175 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amstalden, M.R. Garcia, R.L. Stanko, S.E. Nizielski, C.D. Morrison, D.H. Keisler, and G.L. Williams Central Infusion of Recombinant Ovine Leptin Normalizes Plasma Insulin and Stimulates a Novel Hypersecretion of Luteinizing Hormone after Short-Term Fasting in Mature Beef Cows Biol Reprod, May 1, 2002; 66(5): 1555 - 1561. [Abstract] [Full Text] |
||||
![]() |
M. Guerre-Millo, C. Rouault, P. Poulain, J. Andre, V. Poitout, J. M. Peters, F. J. Gonzalez, J.-C. Fruchart, G. Reach, and B. Staels PPAR-{alpha}-Null Mice Are Protected From High-Fat Diet-Induced Insulin Resistance Diabetes, December 1, 2001; 50(12): 2809 - 2814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Lee and D. R. Romsos Leptin-Deficient Mice Commence Hypersecreting Insulin in Response to Acetylcholine between 1 and 2 Weeks of Age Experimental Biology and Medicine, November 1, 2001; 226(10): 906 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kahn The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058. [Full Text] [PDF] |
||||
![]() |
M. J. Holness and M. C. Sugden Dexamethasone during Late Gestation Exacerbates Peripheral Insulin Resistance and Selectively Targets Glucose-Sensitive Functions in {beta} Cell and Liver Endocrinology, September 1, 2001; 142(9): 3742 - 3748. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamashita, J. Shao, T. Ishizuka, P. J. Klepcyk, P. Muhlenkamp, L. Qiao, N. Hoggard, and J. E. Friedman Leptin Administration Prevents Spontaneous Gestational Diabetes in Heterozygous Leprdb/+ Mice: Effects on Placental Leptin and Fetal Growth Endocrinology, July 1, 2001; 142(7): 2888 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Cases, I. Gabriely, X. H. Ma, X. M. Yang, T. Michaeli, N. Fleischer, L. Rossetti, and N. Barzilai Physiological Increase in Plasma Leptin Markedly Inhibits Insulin Secretion In Vivo Diabetes, February 1, 2001; 50(2): 348 - 352. [Abstract] [Full Text] |
||||
![]() |
T. J. Kieffer and J. F. Habener The adipoinsular axis: effects of leptin on pancreatic beta -cells Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E1 - E14. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ahren and P. J. Havel Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells) Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R959 - R966. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Seufert, T. J. Kieffer, C. A. Leech, G. G. Holz, W. Moritz, C. Ricordi, and J. F. Habener Leptin Suppression of Insulin Secretion and Gene Expression in Human Pancreatic Islets: Implications for the Development of Adipogenic Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 670 - 676. [Abstract] [Full Text] |
||||
![]() |
J. Seufert, T. J. Kieffer, and J. F. Habener Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice PNAS, January 19, 1999; 96(2): 674 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Brockmann, J. Kratzsch, C. S. Haley, U. Renne, M. Schwerin, and S. Karle Single QTL Effects, Epistasis, and Pleiotropy Account for Two-thirds of the Phenotypic F2 Variance of Growth and Obesity in DU6i x DBA/2 Mice Genome Res., December 1, 2000; 10(12): 1941 - 1957. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |